CRISPR opens the door to targeted therapy against glioblastoma (Review)
Year: 2026
Type: article
Institutions: Tianjin University, Tianjin Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7225891613
